Sort
16,179 grants matching “malaria”
Defining the role of platelet-mediated glycocalyx breakdown in driving pathogenic CD8 activity during severe malaria.
$39,995Jenna Susan Reed · University Of Utah · F31 · FY2024 · HL
Immune Responses to Malaria and HIV Infection and Immunization - Clinical Core
$39,964Margaret Juliana McElrath · Seattle Biomedical Research Institute · U19 · FY2018 · AI
THE CAUSES AND CONSEQUENCES OF GENOMIC CHANGE IN PARASITIC OOMYCETES
$39,930Christopher Lane · University Of Rhode Island · P20 · FY2011 · RR
Investigating the targets and strain specificity of antibodies against P. vivax
$39,780Christian Parobek · Univ Of North Carolina Chapel Hill · F30 · FY2017 · AI
HRP2 Mediated Hemozoin Formation in P.falciparum
$39,700University Of California Berkeley · F32 · FY2003 · GM
Cellular Immune Response of Mosquitoes to Pathogens
$39,633University Of Wisconsin Madison · F31 · FY2002 · AI
Tick-borne Relapsing Fever in Mali, West Africa
$39,628Tom Schwan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
The impact of a Hepatitis B birth dose vaccine on HBV immunogenicity and incidence in children in the DRC
$39,600Samantha Tulenko · Univ Of North Carolina Chapel Hill · F30 · FY2022 · AI
Analyzing the function and antibody-mediated inhibition of the malaria vaccine candidate PF3D7_1136200
$39,575Rolando Garza · University Of Texas Hlth Science Center · F30 · FY2025 · AI
Research Project 2: Vector bionomics, vector competence, and insecticide resistance across distinct ecological zones
$39,560Roch Kounbobr Dabire · Colorado State University · U19 · FY2025 · AI
MECHANISMS OF ERYTHROCYTIC INFECTIONS AND ANEMIA: NHP MODEL MALARIAL ANEMIA
$39,499Kasturi Haldar · Emory University · P51 · FY2007 · RR
PLASMODIUM VIVAX MSP-3 AND MSP-9 AS VACCINE IMMUNOGENS
$39,497Mary R Galinski · Emory University · P51 · FY2007 · RR
MOLECULAR BASIS OF ANTIGENIC VARIATION ON MALARIA
$39,497Mary R Galinski · Emory University · P51 · FY2007 · RR
INDUCTION OF PLASMODIUM INFECTIONS TO SUPPORT MALARIA VACCINE STUDIES
$39,497William E Collins · Emory University · P51 · FY2007 · RR
MOLECULAR ANALYSIS OF PLASMODIUM VIVAX SURFACE ANTIGENS
$39,497Mary R Galinski · Emory University · P51 · FY2007 · RR
Characterizing the GTPase activity of a novel contractile ring protein in Plasmodium falciparum
$39,478Madeline Ann Farringer · Harvard University D/B/A Harvard School Of Public Health · F31 · FY2025 · AI
Training in Tropical and Emerging Global Diseases
$39,476Daniel G Colley · University Of Georgia · T32 · FY2011 · AI
Characterizing and targeting malaria parasite purine uptake pathways to generate novel antimalarial drugs
$39,403Yvett D Sosa · Albert Einstein College Of Medicine, Inc · F31 · FY2018 · AI
Epitope Driven HIV Vaccine Development AI50528-01A1
$39,372Anne Searls De Groot · Epivax, Inc. · R03 · FY2006 · TW
Population Genetics of Malaria Parasites in African Hig*
$39,372Guiyun Yan · University Of California-Irvine · R03 · FY2006 · TW
Determinants of Drug Resistant Malaria in Nigeria
$39,372Dyann F Wirth · Harvard School Of Public Health · R03 · FY2006 · TW
Iron Deficiency Anemia and the Pathogenesis of Falciparum Malaria
$39,332Morgan Goheen · Univ Of North Carolina Chapel Hill · F30 · FY2018 · AI
Rebound Malaria Following Trimethoprim-Sulfamethoxazole Prophylaxis in Children
$39,311Taylor Sandison · University Of Washington · K23 · FY2010 · AI
Functional characterization of the Plasmodium falciparum invasion ligand bindome
$39,258Usheer Kanjee · Harvard University D/B/A Harvard School Of Public Health · R21 · FY2025 · AI
The impact of vector control interventions on adverse birth outcomes.
$39,247Michelle Roh · University Of California, San Francisco · F31 · FY2018 · HD